
RxActuator
Founded Year
2017Stage
Unattributed - V | AliveTotal Raised
$1.1MLast Raised
$370K | 8 mos agoAbout RxActuator
RxActuator develops a wearable animal drug delivery pump. Its Mini-Infuser SQ-CRI delivers a drug dose over 48 hours, is used to deliver pain medicine, and allows the animal to move around while receiving therapy. Future uses include providing drug infusion for equine therapies and delivering drugs for cancers, antibiotics, antiemetics, and ophthalmology. The company was founded in 2017 and is based in Tucson, Arizona.
RxActuator Patents
RxActuator has filed 1 patent.
The 3 most popular patent topics include:
- Actuators
- Dosage forms
- Drug delivery devices

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
2/15/2021 | Dosage forms, Drug delivery devices, Fluid dynamics, Actuators, Routes of administration | Application |
Application Date | 2/15/2021 |
---|---|
Grant Date | |
Title | |
Related Topics | Dosage forms, Drug delivery devices, Fluid dynamics, Actuators, Routes of administration |
Status | Application |
Latest RxActuator News
Feb 11, 2020
Breakthrough in drug delivery relies on Covestro polycarbonates 11 February 2020 Wearable drug delivery devices have changed the way medication is administered to patients by shifting treatment from the hospital to the home. However, animals have not had the same freedom during treatment as they often face limited mobility and are kept at animal hospitals. × Breakthrough in drug delivery relies on Covestro polycarbonates Die Mini-Infuser™ SQ-CRI Pumpe der Firma RxActuator verwendet weißes Bayblend® T85 XF PC+ABS-Blend von Covestro für das Gehäuse und klares Makrolon® Rx1805 Polycarbonat in einem Blauton für die Verkleidung.--------------The RxActuator Mini-Infuser™ SQ-CRI pump utilizes white Bayblend® T85 XF PC+ABS blend from Covestro for the case and clear Makrolon® Rx1805 polycarbonate in a blue tint for the trim. Now, a breakthrough in drug delivery is changing how veterinarians deliver pain medication to dogs and cats. The Mini-Infuser Subcutaneous Constant Rate Infusion (SQ-CRI) pump is the first wearable drug delivery device designed for pets, according to RxActuator . By eliminating the possibility of tangled or disconnected IV lines, this device enhances comfort while reducing staff oversight. Polycarbonates meet special requirements The Mini-Infuser pump case features white Bayblend T85 XF PC+ABS blend from Covestro . Additionally, clear Makrolon Rx1805 polycarbonate in a blue tint is used for the device’s trim. RxActuator’s Chief Marketing Officer Doug Nutter said: “Covestro was able to recommend the right polycarbonate grades to help us create an innovative and dog-proof drug delivery device for the veterinary industry.” Simple and cost-effective According to RxActuator, the Mini-Infuser is unique in that it achieves constant and reliable infusion without any electronics. Additionally, it is more cost-effective than a regular infusion pump. The device is distributed by REM Systems in Australia and New Zealand, and sold directly in North America and worldwide by RxActuator. Lauren Zetts, Americas Segment Manager, Healthcare – Polycarbonates, Covestro said: “We think of our four-legged companions as members of our families, so naturally we want them to be as comfortable as possible when medicine must be administered. We appreciate the opportunity to collaborate with RxActuator on an innovative device that does just that.” Tags
RxActuator Frequently Asked Questions (FAQ)
When was RxActuator founded?
RxActuator was founded in 2017.
Where is RxActuator's headquarters?
RxActuator's headquarters is located at 2100 N. Wilmot Road, Tucson.
What is RxActuator's latest funding round?
RxActuator's latest funding round is Unattributed - V.
How much did RxActuator raise?
RxActuator raised a total of $1.1M.